Moneycontrol PRO
HomeNewsBusinessMarketsNifty off highs; auto stocks in focus, Maruti down

Nifty off highs; auto stocks in focus, Maruti down

Auto stocks remained in focus as companies prepare to announce their September sales report card. At 11 am, the market was looking weak. The Sensex came off sharply from its morning highs and was trading only 0.08 percent higher at 26176.80. The Nifty lost its initial proximity to the 8000 level and precariously clung to 7939.50.

October 01, 2015 / 11:47 IST

After beginning the day with great confidence amid a firming trend in other Asian markets following overnight gains on the Wall Street, benchmark indices fell victim to profit booking. At 11 am, the Sensex stocks came off sharply from their morning highs. The index was trading only 0.08 percent higher at 26176.80 while the Nifty lost its initial proximity to the 8000 level and precariously clung to 7939.50. HCL tech remained biggest drag on the Nifty.Auto stocks remained in focus as companies prepare to announce their September  sales report card.  Maruti Suzuki, which had run up the previous few sessions was among the top Sensex losers as it reported slight dent in its annual exports and grew only in single digits. The company's total sales Y-o-Y was higher by 3.7 percent at 1.13 lakh units.Tata Motors, Eicher Motors and Bajaj Auto were other prominent losers in the auto sector while Ashok Leyland, Hero MotoCorp and M&M were gainers.The banking stocks like SBI, ICICI Bank, IDBI Bank, Canara Bank, PFC and IFCI were in focus on news that state-owned Ratnagiri Gas and Power will be split into two ventures - power and LNG terminal to revive the Dhabol power project. The lenders exposure to the project stands at Rs 8,000 crore and the power plant is expected to need refinancing uner the 5:25 rule.Separately, IDFC and Gujarat Gas were buzzing as the former begins trading ex-of the bank business now while the latter comes out of trade-to-trade segment. Pharma stock Strides Arcolab was actively trading after it received tentative US FDA nod for HIV drug Ril-Pivi-Rine. The day also saw traders evincing interestin Everyday after it hiked prices by 50 paisa apiece.Meanwhile a Credit Suisse report indicated that Titan has hinted at a weak quarter on declining jewelry business. Credit Suisse estimates a 20 percent year-on-year dip in the company's jewellery revenues in second quarter.

first published: Oct 1, 2015 10:53 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347